Physiomics (GB:PYC) has released an update.
Physiomics PLC, a leader in mathematical modeling for drug development, has updated its website with a recent investor presentation and Q&A following their End of Year results. The company, known for its Virtual Tumour technology, continues to support pharmaceutical companies like Merck and Astellas with innovative data-driven solutions.
For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.
